Novartis AG
XMUN:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
XMUN:NOT
|
CH |
|
B
|
Boeing Co
XHAM:BCO
|
US |
|
C
|
Credit Agricole SA
XHAM:XCA
|
FR |
|
U
|
United Utilities Group PLC
XMUN:UUEC
|
UK |
|
A
|
Amcor PLC
F:485
|
UK |
|
D
|
Danaher Corp
XMUN:DAP
|
US |
|
R
|
Relx PLC
DUS:RDEB
|
UK |
|
A
|
Applied Materials Inc
XBER:AP2
|
US |
|
Fugro NV
OTC:FUGRF
|
NL |
|
H
|
Hyundai Motor Co
KRX:005385
|
KR |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 135.42 EUR with a low forecast of 100.03 EUR and a high forecast of 159.99 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
135.42
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 135.42 EUR with a low forecast of 100.03 EUR and a high forecast of 159.99 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
